The presence of heat-labile factors interfering with binding analysis of fibrinogen with ferritin in horse plasma by unknown
Takahashi et al. Acta Veterinaria Scandinavica 2013, 55:70
http://www.actavetscand.com/content/55/1/70BRIEF COMMUNICATION Open AccessThe presence of heat-labile factors interfering
with binding analysis of fibrinogen with ferritin in
horse plasma
Kazuma Takahashi1, Takashi Kondo2, Yasunaga Yoshikawa1, Kiyotaka Watanabe1 and Koichi Orino1*Abstract
Background: Horse fibrinogen has been identified as a plasma specific ferritin-binding protein. There are two ways
in the binding of ferritin-binding protein with ferritin: one is direct binding and the other is indirect binding which
is heme-mediated. The aim of this study was to analyze the binding between horse fibrinogen and ferritin.
Findings: Although fibrinogen in horse plasma did not show the binding to ferritin coated on the plate wells, after
following heat-treatment (60°C, 30 min) of horse plasma, plasma fibrinogen as well as purified horse fibrinogen
bound to plates coated with horse spleen ferritin, but not with its apoferritin which lost heme as well as iron after
the treatment of reducing reagent. Binding of purified or plasma fibrinogen to ferritin was inhibited by hemin and
Sn-protoporphyrin IX (Sn-PPIX), but not by PPIX or Zn-PPIX.
Conclusions: Heat-treatment of horse plasma enabled plasma fibrinogen to bind to plate well coated with
holo-ferritin. From the binding analysis of fibrinogen and ferritin, it is suggested that horse fibrinogen recognized
iron or tin in complexed with the heme- or the hemin-ring, and also suggest that some fibrinogens circulate in the
form of a complex with ferritin and/or heat-labile factors which inhibit the binding of fibrinogen with ferritin.
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Ferritin is a ubiquitous iron-binding protein found in
animals, plants, and bacteria [1-3]. Mammalian ferritin
stores iron atoms in the apoferritin shell that is com-
posed of Heavy and Light subunits [1-3]. Intracellular
ferritin also functions in storing a nontoxic form of
iron to prevent its use in the production of hydroxyl
radicals through the iron-mediated Fenton reaction
[2-4]. Serum ferritin is present in relatively low concen-
trations (<1 μg/mL), and serum ferritin is the indicator
of body iron stores [3]. Serum ferritin is also a bio-
marker of several inflammatory diseases as in human
arthritis and bovine intramammary mastitis [3,5].
The following ferritin-binding proteins have been
identified: H-kininogen [3,6], α2-macroglobulin [7,8],
anti-ferritin autoantibodies [3], fibrinogen [9], apolipo-
protein B [3], and α-casein [10]. With the exception of* Correspondence: orino@vmas.kitasato-u.ac.jp
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reproduction in any medium, provided the orα-casein, these proteins most likely function in the re-
moval of circulating ferritin [3,8]. Ferritin-binding proteins
and ferritin may bind directly (e.g., binding between fer-
ritin and H-kininogen or anti-ferritin autoantibody) [3,6]
or indirectly (e.g., heme-mediated binding between ferritin
and apolipoprotein B or α-casein) [3,11].
The purpose of this study was to determine the mech-
anism of horse plasma fibrinogen-ferritin binding. Horse
plasma fibrinogen results in lower concentrations of
ferritin in the plasma than in the serum, but heating at
75°C for 15 min results in equalization of both concen-
trations of ferritin [9,11], suggesting that fibrinogen
binds circulating ferritin. However, in this study, the re-
sults of this binding analysis suggested the existence of
heat-labile factors that inhibits binding between fibrino-
gen and ferritin.
Blood samples were collected from six thoroughbred
horses (age 9–28 years) kept for the research at Kitasato
University and the Equine Research Center, Japan Racing
Association (Tochigi, Japan). Plasma was prepared from
heparinized blood and was kept at 4°C in the presenceral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Binding of horse fibrinogen and fibrinogen in horse
plasma to holoferritin and apoferritin. Plasma from 4 horses was
diluted 100-fold with buffer A and heated at 60°C for 30 min,
followed by centrifugation (14,000 × g, 15 min). Aliquots (100 μL) of
purified horse fibrinogen (1 μg/well) (A) or resulting supernatant
from heat-treated plasma (B) were added to wells of holo- or apo-
ferritin-coated plate (1 pmol/well each). Fibrinogen bound to the
wells was detected as using a goat anti-human fibrinogen antibody
and an ALP-labeled rabbit anti-goat IgG antibody. Each data
represents mean ± SD of four determinations or the average data
from each horse. *: P < 0.01 compared to holoferritin.
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by the following established guidelines for animal
welfare and were approved by the Committee on the
Ethics of Animal Experiments of the Kitasato University
(Permit Number: 11–091).
Commercial horse spleen ferritin (Sigma Chemicals,
St. Louis, MO, USA) was further purified [11] and
its apoferritin was prepared by dialysis of holoferritin
against 100 mmol/L thioglycolic acid in 100 mmol/L
acetate buffer (pH 5.5). Horse plasma samples were
diluted 100-fold with phosphate buffered saline (PBS;
150 mmol/L NaCl, 15 mmol/L dibasic and 5 mmol/L
monosodium phosphate, pH 7.2) containing 0.1% Tween
20 and 0.1% gelatin (buffer A) and heated at 60°C for
30 min and then centrifuged at 14,000 × g for 15 min.
The resulting supernatant was used as heat-treated
plasma. Aliquots (100 μL) of holo- or apo-ferritin solu-
tions in PBS (10 nmol/L each) were added to wells of a
Maxisorp F96 immunoplate (Nunc, Roskilde, Denmark)
and kept overnight at 4°C. The plate wells were washed
three times with PBS containing 0.05% Tween 20 (PBST)
after every step. After washing with PBST, 300 μL of
buffer A was added to each well and masked with gelatin
for 1 h to prevent nonspecific binding. To each well was
also added 100 μL of horse fibrinogen (10 μg/mL) in
ELISA buffer containing 10 mmol/L EDTA (buffer B) or
the heat-treated plasma samples and the plate was incu-
bated at 37°C for 2 h. After washing, 100 μL of goat
anti-human fibrinogen antibody (GenWay Biotech, Inc.,
San Diego, CA, USA) diluted 1000-fold with buffer B
was added to each well and the plate was incubated at
37°C for 1.5 h. The plate was then washed and 100 μL of
alkaline phosphatase (ALP)-labeled rabbit anti-goat IgG
antibody (EMD Merck Millipore, Billerica, MA, USA),
which diluted 1000-fold with buffer A, was added to well
and the plate was incubated at 37°C for 1.5 h. After wash-
ing, the enzyme reaction was performed using 3 mmol/L
disodium p-nitrophenyl phosphate, and absorbance of
each well at 405 nm was measured with Molecular De-
vices VersaMax™ Absorbance Tunable Microplate Reader.
Hemin, Sn-protoporphyrin IX (Sn-PPIX), Zn-PPIX,
and metal-free PPIX were prepared as preciously de-
scribed [10]. These inhibitors were simultaneously added
to fibrinogen (10 μg/mL) in buffer B or heat-treated
plasma (1:100 v/v) to a final concentration of 10 μmol/L.
Aliquots (100 μL) of each mixture were added to
holoferritin-coated wells (1 pmol/well) as described
above. The detection of fibrinogen bound to the wells
was performed as described above except for the use of
buffer A in place of buffer B in every step. All data are
expressed as the mean ± SD, and significant differences
between data from the two groups was assessed using
the Student’s t-test. The significant differences for mul-
tiple comparisons was assessed using one-way ANOVAfollowed by Tukey’s test. A P-value below 0.01 was con-
sidered statistically significant.
The binding mechanism of plasma in horse plasma
and ferritin has not been revealed due to non-binding of
fibrinogen to ferritin. Subjecting horse plasma to heat
treatment at 60°C for 30 min resulted in maximum
binding of plasma fibrinogen to ferritin-coated micro-
wells (Additional file 1: Data S1). Fibrinogen in heated-
treated plasmas showed significant higher binding
activity with holoferritin than with apoferritin as in
purified horse fibrinogen (Figure 1A and B). Human
Takahashi et al. Acta Veterinaria Scandinavica 2013, 55:70 Page 3 of 5
http://www.actavetscand.com/content/55/1/70fibrinogen showed heat stability (68°C, 10 h) in the
pasteurization process [12]. However, heat denaturation
of fibrinogen occurred by divalent cations such as Ca2+
(2 mmol/L) and Zn2+ (20 μmol/L) [13]. Therefore, a
dilution (100-fold) of plasma may eliminate the possibil-
ity of fibrinogen denaturation by heat-treatment and di-
valent cations [14]. Therefore, we suggested that binding
between fibrinogen and ferritin is heme-mediated as in
apolipoprotein B and α-casein because reducing treat-
ment of holoferritin releases heme as well as iron [3,10].
Binding between purified fibrinogen or plasma fibrino-
gen to holoferritin was significantly inhibited by hemin
and Sn-PPIX, but not by Zn-PPIX or metal free-PPIX
(Figure 2A and B) as calculated the binding activity (%)
as 100% for the control in the absence of each inhibitor.
This result agrees with the observation that Sn-PPIX is
the most potent competitive inhibitor of heme oxyge-Figure 2 Inhibition of the binding between holoferritin and purified f
free-, Sn-, or Zn-PPIX. Aliquots (100 μL) of 10 μg/mL of purified horse fibr
“Figure 1” were added to wells of holo-ferritin-coated plate (1 pmol/well) a
free-PPIX (open bar) was added to a final concentration of 10 μmol/L. Fibri
“Figure 1”. Binding activity (%) was determined by comparison to the contr
the binding activity in the presence of hemin; b: P < 0.01 compared to the
the binding activity in the presence of Zn-PPIX. Each data represents meannase reacting with heme as substrate [15]. Binding be-
tween purified fibrinogen or plasma fibrinogen to holo-
ferritin was not blocked by ferrous ammonium sulfate
(Fe2+) or ammonium iron sulfate (Fe3+), even at a con-
centration of 1 mmol/L (data not shown), suggesting
that the binding of fibrinogen to ferritin is not iron-
dependent or not necessary for only iron. These results
demonstrated that horse fibrinogen strongly recognizes
iron or tin complexed with the heme- or the hemin-ring.
Whereas the potency of the inhibitors used to block
binding between purified fibrinogen and holoferritin was
in the order hemin > Sn-PPIX > Zn-PPIX, Sn-PPIX was
the most potent inhibitor when using heat-treated
plasma, and Zn-PPIX did not show any inhibition.
Additionally, PPIX enhanced the binding between
plasma fibrinogen and holoferritin different from puri-
fied fibrinogen. The different inhibitory effects of variousibrinogen or fibrinogen in heat-treated plasma by hemin, metal
inogen (A) or heated-horse plasma sample (B) as described in
nd hemin (solid bar), Sn- (gray bar), Zn- (dotted bar), or metal
nogen bound to the wells was detected as already described in
ol (100%) in the absence of each inhibitor. a: P < 0.01 compared to
binding activity in the presence of Sn-PPIX; c: P < 0.01 compared to
± SD of four determinations.
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fibrinogen and plasma fibrinogen remains to be eluci-
dated. Plasma contains factors such as hemopexin as
a heme-binding protein [16] and albumin and α2-
macroglobulin that bind Zn ion [17], suggesting that
these interactions result in apparent lower inhibitor
concentrations compared to purified fibrinogen.
Plasma may contain some factors that interact with
PPIX to enhance binding activity between fibrinogen
and ferritin.
Why fibrinogen in untreated plasma did not bind
ferritin-coated wells also remains to be determined.
Watanabe et al. [18] reported that the structure of ad-
enylate kinase changes due to denaturation as coated on
plates, resulting in the antigenicity change. This finding
led to the hypothesis that coating plasma proteins on
the wells may release heat-labile factors which inhibit
the binding of fibrinogen to coated ferritin. The fibrino-
gen concentration in this study (10 μg/mL) was esti-
mated to be physiological concentration from plasma
dilution (100-fold) and the normal range (1–2 mg/mL)
[19]. This interference of heat-unstable proteins was ob-
served even after at least one year storage of plasma
sample at 4°C (data not shown), suggesting that plasma
storage did not affect interaction between fibrinogen and
them. It is known that fibrinogen binds IgG [20,21]. We
detected binding between immunoglobulins in untreated
plasma and fibrinogen trapped on the plate by coated
anti-fibrinogen antibody (Additional file 2: Data S2).
Horse IgGT and IgGb showed higher binding activity
with fibrinogen. However, although an attempt to detect
complexes formed between ferritin, fibrinogen, and im-
munoglobulin as fibrinogen-binding protein was not
successful, this findings suggest that fibrinogen partly
circulate as a complex with ferritin and/or a heat-labile
fibrinogen-binding protein, probably IgG.
The high redox potential of iron and heme cause
oxidative damage [3,22]. Ferritin and/or fibrinogen
in horse circulation may protect iron- or heme-
mediated oxidative stress. Additionally, the binding
between them is likely to be involved in local blood
coagulation as in H-kininogen [6]. This study may
also provide preliminary data on physiological rela-
tion between iron metabolism and blood coagulation
system.
In conclusion, plasma fibrinogen bound to coated fer-
ritin only after plasma was heated (60°C, 30 min). Horse
fibrinogen bound holo-ferritin, but not apo-ferritin also
having no heme. Binding of fibrinogen to ferritin was
inhibited by hemin and Sn-PPIX, but not by metal-free
PPIX or Zn-PPIX. This study demonstrates that horse
fibrinogen binds ferritin through heme-mediation, and
that plasma heat-labile factors inhibit the binding be-
tween them.Additional files
Additional file 1: Data S1. The effect of heat treatment of horse plasma
on the binding of plasma fibrinogen to coated ferritin. Plasma from 3 horses
was diluted 100-fold with buffer A was heated at the temperature indicated
for 30 min, followed by centrifugation at 14,000 × g for 15 min. Aliquots
(100 μL) of the resulting supernatant were added to wells of a commercial
horse spleen ferritin-coated immunoassay plate (1 pmol/well). Fibrinogen
bound to the wells was detected using a goat anti-human fibrinogen
antibody and an ALP-labeled rabbit anti-goat IgG antibody. Data represents
mean ± SD of the average data from each horse.
Additional file 2: Data S2. The detection of immunoglobulin G binding
to fibrinogen in plasma from 3 horses. Aliquots (100 μL) of sheep anti-
human fibrinogen antibody (AbD Serotec, Inc., Raleigh, NC, USA) diluted
with PBS were added to wells (90 μg/well), and the plate was kept
overnight at 4°C. After washing and masking with gelatin, 100 μL of
horse plasma diluted 200-fold with buffer A was added to the well, and
incubated at 37°C for 2 h. After washing, 100 μL of monoclonal
antibodies to IgGa, IgGb, IgG or IgGT diluted with buffer A was added to
the wells. The immunoglobulin bound to fibrinogen in horse plasma was
detected with an ALP-labeled goat anti-mouse IgG antibody
(SouthernBiotech Assoc., Birmingham, AL, USA). Data represents
mean ± SD of the average data from each horse.
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